Login
$CRVS
$10.45 -$0.08 (0.76%) Close

$CRVS SEC Filings

Filed On Filing
07 Aug 2026 SCHEDULE 13G
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition
27 Jul 2026 SCHEDULE 13G/A
22 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation
15 Jun 2026 Form 4: Moore David Scott, Director

Bought 21,700 shares ($250K) · Granted 15,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: Clark Ian T, Director

Granted 15,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: Grais Linda, Director

Granted 15,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: Thompson Peter A., Director

Granted 15,000 Stock Option (Right to Buy)

15 Jun 2026 Form 4: van den Broek Richard, Director

Granted 15,000 Stock Option (Right to Buy)

12 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders
20 May 2026 Form 4: Miller Richard A Md, Director

Bought 6,932 shares ($83.5K)

15 May 2026 SCHEDULE 13G/A
15 May 2026 SCHEDULE 13G
14 May 2026 8-K: Regulation FD Disclosure; Other Events
07 May 2026 FORM S-8
07 May 2026 10-Q
07 May 2026 8-K: Results of Operations and Financial Condition
27 Apr 2026 Form 4: Chan Andrew C., Director

Granted 30,000 Stock Option (Right to Buy)

27 Apr 2026 Form 3: Chan Andrew C., Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support